menu
faruqi and faruqi novavax recent update
faruqi and faruqi novavax recent update
faruqi and faruqi novavax recent update

Partners in Securities Litigation James (Josh) Wilson Encourages Investors who have suffered losses of more than $200,000 In Novavax to contact him directly To Discuss Their Options

New York, New York--(Newsfile Corporation. - - October 24 2021) (Newsfile Corp. - October 24, 2021) Faruqi & Faruqi, LLP, a prominent national securities law firm, is investigating potential allegations against Novavax ("Novavax, Inc." ("Novavax, Inc.") or "Company") (NASDAQ: NVAX).

If you've suffered losses that exceed $200,000 in Novavax stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 , or 212-983-9330 (Ext. 1310). You may also click here Faruqi and Faruqi for additional information: http://www.faruqilaw.com/NVAX.

Faruqi & https://www.linkedin.com/company/faruqi-&-faruqi-llp Faruqi is a top minority and women-owned national securities law firm , with locations across New York, Delaware, Pennsylvania, California and Georgia.

On the 19th of October, 2021, after the market had closed, Politico published an article in the form of "'They Rushed the Process': Vaccine Maker's woes hamper global inoculation campaign", in which they stated the "manufacturing problems are jeopardizing billions of doses earmarked for poor and middle-income countries." The article also stated the following "[a]lthough Novavax recently attested to some of its analytics and testing issues ... the company's issues are